Stay updated on Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial page.

Latest updates to the Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial page
- Check6 days agoChange DetectedA new site revision entry (v3.5.2) was added to the history and the older revision (v3.5.0) was removed. This is a backend/system update that does not modify study data or user-facing content.SummaryDifference0.0%

- Check13 days agoChange DetectedAdded a Study Status section on 2026-04-06; deleted an entry dated 2026-02-19.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedRevision v3.5.0 was added to the record history and Revision v3.4.3 was removed.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page's revision tag was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check56 days agoChange DetectedIPDSharing and Study Status entries were added to the record history (version 87, dated 2026-02-19), updating the study's data-sharing policy and current status.SummaryDifference0.2%

- Check70 days agoChange DetectedNew revision entry v3.4.2 has been added; the funding lapse notice and Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial page.